Tech transfer offices were mainly used for patent filing and license negotiations for the majority of their existence. Prevent lawsuits, collect royalties, and safeguard the university’s intellectual property. In essence, the mission was defensive. However, the most astute TTOs began posing a different query at some point: what if we actually supported these businesses ourselves? What if we went out and told the market that these discoveries were worthwhile instead of waiting for them to be discovered?

This is supported by the research in ways that are difficult to dispute. When a TTO gave early “gap funding” to a spinoff, it did more than just help the business survive its first year, according to a study that looked at every spinoff made from University of Michigan inventions between 1999 and 2010.

Venture capitalists’ perception of the investment was functionally altered. The TTO’s money functioned more as a credibility stamp than as charity. When a university placed a wager, private VCs were significantly more inclined to follow with their own funds.

This may seem straightforward, even apparent. However, it reveals a more nuanced aspect of the information flow within startup ecosystems. The discrepancy between the founders’ knowledge and what outside investors can truly confirm has always been the issue with academic spinoffs.

Even if a researcher has spent seven years creating a breakthrough in materials science, a venture capitalist assessing it during a two-hour pitch session is essentially blind. Some of that uncertainty is absorbed by the TTO, which sits closer to the science and the scientists. It communicates something that a pitch deck just cannot when it writes a check.

Since the Bayh-Dole Act gave universities the right to own federally funded research back in 1980, TTOs seem to have been quietly preparing for this moment. Stanford and MIT were the pioneers, creating businesses that later transformed entire sectors. However, those were exceptions, and they continued to be so for many years.

These days, mid-tier research universities, which have serious science departments but do not have Silicon Valley zip codes, are trying to construct the same equipment. Those with experience in investing are being hired. They are conducting portfolio-style evaluations. Five years ago, their approach to deal structure would have seemed inappropriate in a faculty meeting.

It’s still genuinely unclear if they can all pull it off. The talent and network are the problem, not the funding model. Hundreds of downstream investors and operators are connected to a San Francisco venture capital firm. At least not yet, a TTO in the Midwest lacks that rolodex.

Even though they are often brilliant, academic founders often lack the business acumen that investors seek before making significant financial commitments. In the end, the TTO juggles the roles of coach, matchmaker, and guarantor at the same time—a skill that most universities are still developing.

Nevertheless, it’s difficult to ignore the impression that something truly fascinating is taking place at the nexus of private funding and scholarly research. For the type of scientific investment that public universities represent, the previous model—file a patent, license it to a corporation, and cash a royalty check—was always a poor return. The new model is more costly, messier, and more difficult to operate. However, it’s also more in line with what science truly merits.

The post Why Tech Transfer Departments at Major Universities Are Suddenly Operating Like Silicon Valley VC Firms appeared first on Creative Learning Guild.